LOW VALUATION ON HENRY SCHEIN AT $65.12 (HSIC-US)
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services.
JUSTIFICATION HSIC has weakened for 2 reasons: 1) The company is being investigated for breaking anti-trust laws with other dental suppliers and 2) Amazon has been talking about entering the dental supply space. This company is among the top 20 Purple Chips stocks that we follow and we have a high degree of confidence that these short term issues will blow over. The Purple Chips 12 -18 month target is $78.00.
